European Union - English - EMA (European Medicines Agency)

ipsen pharma - mecasermin - laron syndrome - pituitary and hypothalamic hormones and analogues - for the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary igfd).severe primary igfd is defined by:height standard deviation score ≤ -3.0 and;basal insulin-like growth factor-1 (igf-1) levels below the 2.5th percentile for age and gender and;growth hormone (gh) sufficiency;exclusion of secondary forms of igf-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.severe primary igfd includes patients with mutations in the gh receptor (ghr), post-ghr signalling pathway, and igf-1 gene defects; they are not gh deficient, and therefore, they cannot be expected to respond adequately to exogenous gh treatment. it is recommended to confirm the diagnosis by conducting an igf-1 generation test.

Australia - English - Department of Health (Therapeutic Goods Administration)

global therapeutics pty ltd - ascorbic acid,pyridoxine hydrochloride,sodium ascorbate,zinc glycinate -

Australia - English - Department of Health (Therapeutic Goods Administration)

health world ltd - pyridoxine hydrochloride,selenomethionine,zinc amino acid chelate,zinc sulfate monohydrate -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - zinc chloride 5.3 mg/ml equivalent to 5.1 mg zn/2ml - solution for injection - 10.6 mg/2ml - active: zinc chloride 5.3 mg/ml equivalent to 5.1 mg zn/2ml excipient: water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

global therapeutics pty ltd - ascorbic acid,pyridoxine hydrochloride,sodium ascorbate,zinc glycinate -

Australia - English - Department of Health (Therapeutic Goods Administration)

phytologic holdings pty limited - zinc citrate dihydrate, quantity: 155.8 mg (equivalent: zinc, qty 50 mg) - capsule, hard - excipient ingredients: magnesium stearate; microcrystalline cellulose; gelatin - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support healthy eye function ; maintain/support eye health ; helps maintain/support eye macula health ; maintain/support healthy eyesight/vision ; maintain/support general health and wellbeing ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support immune system health ; maintain/support healthy immune system function ; aid/assist/helps protein synthesis in the body ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support reproductive system health ; maintain/support sperm health ; maintain/support testosterone level ; relieve symptoms of acne ; helps reduce occurrence of symptoms of acne ; maintain/support skin health ; maintain/support skin integrity/structure ; maintain/support skin regeneration

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - zinc; ascorbic acid; biotin; cyanocobalamin; folic acid; nicotinamide; pantothenic acid; pyridoxine; riboflavin; calcium; chromium; copper; iodine; iron; ergocalciferol; tocopheryl acetate; selenium; vitamin a; thiamine; magnesium; manganese; molybdenum; potassium; phosphorus - oral capsule - 15mg ; 60mg ; 100microgram ; 3microgram ; 400microgram ; 18mg ; 4mg ; 2mg ; 1.6mg ; 100mg ; 200microgram ; 2mg ; 140microgram ; 12mg ; 400unit ; 10mg ; 50microgram ; 2500unit ; 1.2mg ; 30mg ; 3mg ; 250microgram ; 4mg ; 77mg

Australia - English - Department of Health (Therapeutic Goods Administration)

care essentials pharmaust pty ltd - castor oil, quantity: 500 mg/g; zinc oxide, quantity: 75 mg/g - cream - excipient ingredients: cetostearyl alcohol; white beeswax; arachis oil; butylated hydroxyanisole - decrease/reduce/relieve skin irritation

Canada - English - Health Canada

amgen canada inc - blinatumomab - powder for solution - 38.5mcg - blinatumomab 38.5mcg - antineoplastic agents

Israel - English - Ministry of Health

novartis israel ltd - inclisiran as sodium - solution for injection - inclisiran as sodium 189 mg/ml - inclisiran - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or mixed dyslipidaemia, as an adjunct to diet:• in combination with a statin or statin with other lipid lowering therapies in patients unable to reach ldl c goals with the maximum tolerated dose of a statin, or• alone or in combination with other lipid lowering therapies in patients who are statin intolerant, or for whom a statin is contraindicated.